Researchers analyzed 11 studies involving very preterm infants to look at the effects of early postnatal antibiotic exposure. The goal was to see how these medications impact health outcomes like lung disease and infection.
The analysis found that infants who received early antibiotics had a higher risk of developing bronchopulmonary dysplasia, which is a chronic lung condition. There was also a significant increase in the risk of necrotizing enterocolitis, a serious intestinal condition, and an increased risk of mortality. No clear link was found between early antibiotic use and late-onset sepsis.
Because these findings come from observational data, they show a link rather than a direct cause. Some results regarding mortality should be viewed with caution because of potential publication bias in the original studies. These findings suggest that while antibiotics are necessary for some infections, their timing and use in very preterm infants may have associated risks.
Common questions
What are the risks of early antibiotics for premature babies?
The study found that early postnatal antibiotic exposure is associated with an increased risk of bronchopulmonary dysplasia (BPD) and necrotizing enterocolitis (NEC). These are serious conditions affecting the lungs and intestines. While the data shows a link, it does not prove that antibiotics cause these issues directly.
Does early antibiotic use affect survival rates in preterm infants?
The analysis showed a significantly increased risk of mortality for very preterm infants exposed to early antibiotics. However, researchers note that this specific finding should be interpreted with caution because of potential publication bias in the included studies.
Does early antibiotic use lead to more infections like sepsis?
The study found no statistically significant association between early postnatal antibiotic exposure and late-onset sepsis (LOS). This means the data did not show a clear link between the timing of antibiotics and this specific type of infection.
